| Manuela Botero, | |
|
1209 Lochshyre Ct, Lawrenceville, GA 30043-4474 | |
| (404) 966-5071 | |
| Not Available |
| Full Name | Manuela Botero |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 7 Years |
| Location | 1209 Lochshyre Ct, Lawrenceville, Georgia |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194252379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastside Medical Center | Snellville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Anesthesia Of Georgia Llc | 6608123724 | 47 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Entity Name | Capitol Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245287192 PECOS PAC ID: 5799774642 Enrollment ID: O20040507000216 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Entity Name | Physician Specialists In Anesthesia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316968662 PECOS PAC ID: 9830170059 Enrollment ID: O20040525000912 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Entity Name | American Anesthesiology Associates Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528068673 PECOS PAC ID: 7618934779 Enrollment ID: O20041210000442 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Entity Name | Premier Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811403207 PECOS PAC ID: 6608123724 Enrollment ID: O20180720001402 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manuela Botero, 1209 Lochshyre Ct, Lawrenceville, GA 30043-4474 Ph: () - | Manuela Botero, 1209 Lochshyre Ct, Lawrenceville, GA 30043-4474 Ph: (404) 966-5071 |
News Archive
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
A paper by a University of Hertfordshire academic due to be published tomorrow (29 January 2010), reports that excess ecstasy-related death rates in young users is a cause for concern.
Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.
Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent - exceeding the high-end of the company's guidance.
Runners who wear trainers with no cushioning and land on the ball of their foot rather than the heel put significantly less demand on their bodies, new research suggests.
› Verified 1 days ago
Heather Gail Kotula, PAAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-963-9905 | |
Mr. Thomas J Glancy, PA-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Kapildev Kumar Ganesh Prasad, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Lisa D Marrero, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Jason C Colier, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Ms. Lin Thi Bui, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 770-277-3056 Fax: 855-204-5244 | |
Tuan Le Anh Bui, MD Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 771 Old Norcross Rd, Suites 155 And 390, Lawrenceville, GA 30046 Phone: 678-957-0757 Fax: 678-957-9597 |